Fig. 6From: Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acidsButyrate increased systemic SCFA levels in diabetic mice. A The pie chart shows the relative proportions of SCFAs in the T1D, T1D + NaB, and control groups. B Butyric acid, 4-methylvaleric acid, and caproic acid levels in plasma significantly decreased in the T1D group compared with the control group. C The concentrations of total and individual SCFAs were calculated. Data are presented as the mean ± SEM. SCFAs, Short-chain fatty acids. **p < 0.01, ***p < 0.001, n = 5Back to article page